ARCHIVES

New Drug Reverses Damage To Liver In Stem Cell Transplant

This article is from The Cancer Letter archive.

Vol. 25 No. 9 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

Program Announcements

August 3, 2001

Hrushesky To Pursue Chronobiology Work At Albany, Forms Group

April 28, 1989

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

November 26, 2014

NCI-Approved Clinical Trials Listed For May 2001

June 29, 2001

Brandt Tells NIK There May Be No Exceptions To DRG Regulations, Maybe a Few At Comprehensive Centers

June 24, 1983

EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation

May 30, 2014